Old Web
English
Sign In
Acemap
>
authorDetail
>
Tolson Jm
Tolson Jm
Ofatumumab
Multiple sclerosis
Medicine
Dose-ranging study
Adverse effect
3
Papers
104
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study
2018
Neurology
Amit Bar-Or
Richard A. Grove
Daren Austin
Tolson Jm
Susan Vanmeter
Eric W. Lewis
Frederick J. Derosier
Monica C. Lopez
Sarah T. Kavanagh
Aaron E. Miller
Per Soelberg Sørensen
Show All
Source
Cite
Save
Citations (77)
Follow-Up Data From the MIRROR Study: A Dose-Ranging Study of Subcutaneous Ofatumumab in Subjects With Relapsing-Remitting Multiple Sclerosis
2014
Per Soelberg Sørensen
Kavanagh St
Daren Austin
Richard A. Grove
López Mc
Tolson Jm
Susan Vanmeter
Amit Bar-Or
Show All
Source
Cite
Save
Citations (6)
The MIRROR Study: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Investigate the Safety and MRI Efficacy of Subcutaneous Ofatumumab in Subjects with Relapsing-Remitting Multiple Sclerosis (RRMS) (S23.006)
2014
Neurology
Amit Bar-Or
Richard A. Grove
Daren Austin
Tolson Jm
Susan Vanmeter
Eric W. Lewis
Per Solberg Sorensen
Show All
Source
Cite
Save
Citations (21)
1